SALT
LAKE CITY, May 9, 2023 /PRNewswire/
-- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or
"Co-Dx"), a molecular diagnostics company with a unique, patented
platform for the development of molecular diagnostic tests,
announced today that it is hosting a booth at Argentum's 2023
Senior Living Executive Conference and Expo, being held
May 8-10 in New Orleans, LA.
The conference is the official meeting of Argentum, the leading
national association exclusively dedicated to supporting companies
operating professionally managed, resident-centered senior living,
and is described as an opportunity to connect with thousands of
executives and experts in the senior living space, with over 750
exhibiting companies and thousands of participants.
The Company's booth will showcase Co-Diagnostics' upcoming Co-Dx
PCR Home™ testing platform and its planned pipeline of respiratory
disease diagnostics, including COVID-19, influenza, RSV and
tuberculosis.
More information about the conference may be found here.
Attendees interested in learning more about the Company and its
upcoming Co-Dx PCR Home platform, which is subject to FDA review
and is not available for sale, are invited to visit the Company's
booth.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah
corporation, is a molecular diagnostics company that develops,
manufactures and markets state-of-the-art diagnostics technologies.
The Company's technologies are utilized for tests that are designed
using the detection and/or analysis of nucleic acid molecules (DNA
or RNA). The Company also uses its proprietary technology to design
specific tests for its Co-Dx PCR Home™ platform and to locate
genetic markers for use in applications other than infectious
disease.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-senior-living-executive-conference-in-new-orleans-la-301819406.html
SOURCE Co-Diagnostics